ArticleAnnals of hematology2026
Efficacy and safety of belumosudil for refractory chronic graft-versus-host disease in routine practice.
Garret M K Leung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it